Essentra to Acquire Clondalkin's Specialist Packaging Division
Essentra has signed an agreement to acquire Clondalkin's Specialist Packaging Division for a cash consideration of approximately $455 million.
Essentra has signed an agreement to acquire Clondalkin’s Specialist Packaging Division for a cash consideration of approximately $455 million. According to the press release, the transaction marks Essentra’s largest acquisition to date and is expected to complete in the first quarter of 2015.
Clondalkin SPD is a global provider of speciality secondary packaging solutions for the pharmaceutical and health and personal care industries, with 24 facilities. It is believed that the acquisition will add to Essentra’s position in these markets.
Source: Essentra
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
